Skip to main content

Day: May 17, 2021

Minim to Set New Price and Performance Bar this Fall with Next-Generation Motorola WiFi 6 Product Family

MinimMinim To Set New Price and Performance Bar This Fall With Next-Generation Motorola WiFi 6 Product FamilyMinim Announces Ultra-High-Speed, Low-Latency Motorola Lineup of AX Products, Including the “Luxury Cars” of Cable Modem/Routers— Coming Early Fall and Available for Pre-Order Today MANCHESTER, NH, May 17, 2021 (GLOBE NEWSWIRE) — via NewMediaWire ‒ Zoom Telephonics, Inc., doing business as Minim (OTCQB: MINM), the creator of innovative internet access products under the globally-recognized Motorola® brand, today announced the company’s highly anticipated Motorola WiFi 6 product family and an intelligent mobile app, motosync. As WiFi 6 (“AX”) brings speeds up to 250% faster than the previous WiFi standard, the Motorola family of AX products will join the estimated two billion WiFi 6 device shipments in 2021...

Continue reading

US Genetic Testing Market Size 2021 | Is Expected to Gain Momentum by Reaching USD 10.29 Billion by 2027 while Exhibiting an Impressive CAGR of 13.0%

Top Players Covered in the US Genetic Testing Market Research Report Are Invitae Corporation (San Francisco, U.S.), Ambry Genetics (Aliso Viejo, U.S.), BioReference Laboratories, Inc. (Elmwood Park, U.S.), Progenity, Inc. (San Diego, U.S.), Quest Diagnostics Incorporated (Secaucus, U.S.), Myriad Genetics, Inc. (Salt Lake City, U.S.), Fulgent Genetics (Temple City, U.S.), Burning Rock Biotech Limited (Guangzhou, China) and other key market players. Pune, India, May 17, 2021 (GLOBE NEWSWIRE) — US Genetic Testing Market Size| 2021 Covid-19 Impact On Automotive Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional Forecast To 2026 is latest study published by Fortune Business Insights. The US Genetic Testing Market size is expected to gain momentum by...

Continue reading

GT Gold Corp. Announces Completion of Acquisition by Newmont Corporation

VANCOUVER, British Columbia, May 17, 2021 (GLOBE NEWSWIRE) — GT Gold Corp. (TSX-V:GTT; OTCQX:GTGDF) (the “Company” or “GT Gold”) is pleased to announce the successful completion of the previously-announced plan of arrangement with Newmont Corporation i under the Business Corporations Act (British Columbia) (the “Arrangement”). Pursuant to the Arrangement, Newmont has acquired the remaining 85.1% of the outstanding common shares of the Company not already owned by Newmont or its affiliates. Upon completion of the Arrangement, GT Gold became an indirect wholly-owned subsidiary of Newmont. “Newmont is excited to have the Tatogga project in the highly-sought after Golden Triangle district of British Columbia, Canada, become part of our world-class portfolio and part of our future,” said Newmont President and CEO Tom Palmer. “We look...

Continue reading

Landos Biopharma Reports First Quarter 2021 Financial Results and Provides Business Updates

Completed initial public offering of common stock, raising approximately $100 million in gross proceeds Following positive Phase 2 results of omilancor in ulcerative colitis, including statistically significant immunological and biomarker results, end-of-Phase 2 Meeting with FDA planned for Q2 2021 Announced a potentially $218 million exclusive development and commercialization agreement with LianBio to conduct two clinical trials for omilancor and NX-13 in Greater China and select Asian markets  Company expects to file at least three INDs in 2021 BLACKSBURG, Va., May 17, 2021 (GLOBE NEWSWIRE) — Landos Biopharma, Inc (NASDAQ: LABP), a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutics for patients with autoimmune diseases, today announced financial results for the first quarter ended...

Continue reading

The special investment fund Impakti becomes part of Aktia’s product portfolio

Aktia Bank PlcPress release17 May 2021 at 2.15 p.m. The special investment fund Impakti becomes part of Aktia’s product portfolio On 30 April 2021, Aktia announced that it had acquired the wealth management operations of Taaleri. As a result of the arrangement, the special investment fund Taaleri Impakti becomes part of Aktia’s product portfolio. The objective of the fund is to impact society and the environment in a positive way by investing funds in the stock market, the interest rate markets and alternative investments either directly or through other funds. The Impakti fund invests in, among other things, wind and solar energy as well as projects promoting environmental protection and energy efficiency. The globally investing fund aims to mitigate the effects of climate change, air and marine pollution as well as poverty and...

Continue reading

Medivolve Expands Portfolio of Pharmacy Acquisitions with Agreement to Acquire Outstanding Shares of CalVax Licensed Marbella Pharmacy

Acquisition will give Medivolve immediate access to pharmaceutical distribution and CalVax licensing throughout CA; near term COVID-19 vaccination allocations to follow TORONTO, May 17, 2021 (GLOBE NEWSWIRE) — Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) a healthcare technology and services company, today announced it has signed a binding agreement to acquire 100% of all outstanding shares of Marbella, a nonsterile compounded California state licensed and insured pharmacy. This acquisition advances Medivolve’s growth strategy and expands its ability to deliver patient care through immediate access to pharmaceutical distribution throughout the state of California. “The acquisition of Marbella Pharmacy is an important step forward in executing on our strategic growth strategy,” said David Preiner, CEO of Medivolve....

Continue reading

Aerpio Pharmaceuticals and Aadi Bioscience Enter into a Definitive Merger Agreement

Transaction to create Nasdaq-listed company focused on advancing Aadi Bioscience’s late-stage pipeline for genetically-defined cancers with alterations in mTOR pathway genes Concurrent $155 million PIPE financing is backed by leading life science investors led by Acuta Capital Partners and KVP Capital and including Avoro Capital Advisors; Avoro Ventures; Venrock Healthcare Capital Partners; BVF Partners, L.P.; Vivo Capital; Alta Bioequities, L.P.; Rock Springs Capital; RTW Investments, LP; Acorn Bioventures; and Serrado Capital LLC Combined company cash at closing will fund operations into 2024Rolling NDA submission to the FDA for FYARROTM in advanced malignant perivascular epithelioid sarcoma (PEComa) expected to be completed in mid-2021 FYARROTM preliminary data in patients with solid tumors harboring inactivating alterations in the...

Continue reading

Houseworks Announces Acquisition of Intervention Associates, a Leading Care Management Company Serving Greater Philadelphia

BOSTON & PHILADELPHIA, May 17, 2021 (GLOBE NEWSWIRE) —HouseWorks, one of the nation’s largest independent home care companies, announced today that it has acquired Intervention Associates, a leading care management company that has served Greater Philadelphia for more than 30 years. The acquisition of Intervention Associates adds bench strength to the HouseWorks family of companies’ in-home care services that are offered through Caring Friends Home Care in Greater Philadelphia.  Intervention Associates’ talented and experienced care managers will significantly enhance Caring Friends’ ability to provide specialized services to clients and families —becoming their ‘quarterbacks’ as they navigate every possible challenge of aging at home. Michael Trigilio, CEO of HouseWorks commented: “I am thrilled to welcome the Intervention...

Continue reading

Gran Colombia Declares Monthly Dividend to Be Paid on June 15, 2021

TORONTO, May 17, 2021 (GLOBE NEWSWIRE) — Gran Colombia Gold Corp. (TSX: GCM; OTCQX: TPRFF) announced today that its Board of Directors has declared the next monthly dividend of CA$0.015 per common share will be paid on June 15, 2021 to shareholders of record as of the close of business on May 31, 2021. About Gran Colombia Gold Corp. Gran Colombia is a Canadian-based mid-tier gold producer with its primary focus in Colombia where it is currently the largest underground gold and silver producer with several mines in operation at its high-grade Segovia Operations. Gran Colombia’s portfolio includes equity positions in several listed companies advancing gold and silver projects including a 44.3% equity interest in Aris Gold Corporation (TSX: ARIS) (Colombia – Marmato; Canada – Juby), a 17.8% equity interest in Gold X Mining Corp. (TSX-V:...

Continue reading

AAON Announces Semi-Annual Cash Dividend and Promotion of Christopher D. Eason

TULSA, Okla., May 17, 2021 (GLOBE NEWSWIRE) — AAON, Inc. (NASDAQ-AAON), today announced that its Board of Directors has declared the Company’s next regular semi-annual cash dividend of $0.19 per share (or $0.38 annually), payable on July 1, 2021 to stockholders of record as of the close of business on June 3, 2021. The Company also announced today that its Board of Directors has promoted Christopher D. Eason to the position of Chief Accounting Officer, effective May 11, 2021. Christopher D. Eason, 39, joined AAON in 2018 as Controller and Financial Reporting Manager. Prior to joining the Company, he served as a Senior Manager at Grant Thornton, LLP, where he had 13 years of experience in the assurance division. Mr. Eason is a licensed certified public accountant and graduated from Oklahoma State University with a Bachelor of Science...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.